| Health Care Technology Industry | Healthcare Sector | Michael S. Ross CEO | OTC PINK Exchange | 918099201 CUSIP |
| US Country | 1 Employees | - Last Dividend | 20 Jan 2012 Last Split | - IPO Date |
UV Flu Technologies, Inc. is a company specialized in the development, manufacture, and sale of advanced air purification systems and products, especially within the United States. Founded in 2006, it initially operated under the name Northwest Chariots Incorporated until it was rebranded to UV Flu Technologies, Inc. in November 2009. The company's headquarters are situated in Lincolnshire, Illinois. It primarily focuses on leveraging high-intensity germicidal ultraviolet radiation technology to create environments that are not just filtered but sanitized, aiming to eliminate harmful microbes effectively. UV Flu Technologies caters to a broad array of sectors including hospitality, healthcare, beauty, animal care, research, gaming, and military, indicating a versatile application of its products.
The flagship product of UV Flu Technologies, the ViraTech UV-400, stands out through its use of high-intensity germicidal ultraviolet radiation. This method goes beyond traditional filtering, incorporating a killing chamber designed to trap and then destroy harmful microbes. The device is engineered for efficiency and safety, embodying the company's innovation in tackling air quality concerns.
This series includes HEPA-based air purifiers that complement the UV offerings by providing a mechanical filtration solution. These products are designed to capture and filter out particles, including dust, pollen, and other allergens, from the air. The RX Air product line further diversifies UV Flu Technologies' approach to creating cleaner, healthier indoor environments.